Hi, I was an investor in this counter two years ago. I made 30% in six months and exited.
The problem with GTBL is that it’s just a two-trick pony. There are only two products at present. When the 200cr capex will come and how much sales it will generate are the questions for the future.
There are not many optionalities. And if you compare the valuations, it is neck and neck with Giants like Divis, which is not only the largest producer in many APIs but has a large number of molecules (optionalities)
So basically, only 2 molecules and RICH valuations, prevent me from entering this counter.
Just tracking.
dr.vikas
Subscribe To Our Free Newsletter |